Wakefield Asset Management Lllp Myriad Genetics Inc Transaction History

Wakefield Asset Management Lllp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 06, 2019	SELL	$26.93 - $34.7 $347,208 - $447,387	-12,893 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$27.23 - $45.56 $154,775 - $258,963	5,684 Added 78.85%	12,893 $375,000
Q3 2018 Nov 15, 2018	BUY	$37.57 - $50.34 $270,842 - $362,901	7,209 New	7,209 $332,000

238

92.7M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.